Clinical Trial Update: Phase 1b Clinical Trial to Evaluate PEP and EUFLEXXA for Knee Osteoarthritis (KOA) [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1b study evaluating PEP and EUFLEXXA for knee osteoarthritis, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Euflexxa (sodium hyaluronate)
• PEP

Snippet

Sponsor: Rion Inc. | Conditions: Knee Osteoarthritis | Phase 1 | Status: NOT_YET_RECRUITING